Publications
- Rituximab maintenance versus observation alone in patients with chronic lymphocytic leukaemia who respond to first-line or second-line rituximab-containing chemoimmunotherapy: final results of the AGMT CLL-8a Mabtenance randomised trial2016 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové, Third Faculty of Medicine
- Recommendations for the diagnosis and treatment of chronic lymphocytic leukaemia (CLL) Czech Group for Chronic Lymphocytic Leukaemia, section of the Czech Society of Haematology, CzMA2016 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Recommendations for the diagnosis and treatment of chronic lymphocytic leukaemia (CLL)2013 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové, Faculty of Medicine in Pilsen, Third Faculty of Medicine
- Chronic lymphocytic leukaemia2013 | First Faculty of Medicine
- Advances in the treatment of chronic lymphocytic leukaemia2013 | First Faculty of Medicine
- Modern and conventional prognostic markers of chronic lymphocytic leukaemia in the everyday haematological practice2011 | First Faculty of Medicine
- Prospective observational study in comorbid patients with chronic lymphocytic leukemia receiving first-line bendamustine with rituximab2019 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové, Third Faculty of Medicine
- Rituximab maintenance overcomes the negative prognostic factor of obesity in CLL: Subgroup analysis of the international randomized AGMT CLL-8a mabtenance trial2019 | Central Library of Charles University, First Faculty of Medicine, Faculty of Medicine in Hradec Králové
- MiR-155/miR-150 network regulates progression through the disease phases of chronic lymphocytic leukemia2017 | First Faculty of Medicine, Faculty of Mathematics and Physics
- Léčebné postupy v hematologii2016 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové
Loading network view...